Coty Inc.: Form 10-Q for the period ended Dec 31, 2017
Filed with the SEC on Feb 8, 2018 and accepted by EDGAR at Feb 8, 2018, 16:02 ET.
Sections
The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. The main document on sec.gov.
Figures reported in this filing
Standardized line items from the XBRL in this filing, for the period ended 2017-12-31. Comparative periods it repeats are left out.
| Line item | Period | Value | XBRL concept |
|---|---|---|---|
| Gross profit | 3 months2017-10-01 to 2017-12-31 | $1.61bn | us-gaap:GrossProfit |
| Gross profit | 6 months2017-07-01 to 2017-12-31 | $2.98bn | us-gaap:GrossProfit |
| Selling, general and administrative | 3 months2017-10-01 to 2017-12-31 | $1.32bn | us-gaap:SellingGeneralAndAdministrativeExpense |
| Selling, general and administrative | 6 months2017-07-01 to 2017-12-31 | $2.51bn | us-gaap:SellingGeneralAndAdministrativeExpense |
| Operating income | 3 months2017-10-01 to 2017-12-31 | $174.4m | us-gaap:OperatingIncomeLoss |
| Operating income | 6 months2017-07-01 to 2017-12-31 | $203.1m | us-gaap:OperatingIncomeLoss |
| Interest expense | 3 months2017-10-01 to 2017-12-31 | $69.6m | us-gaap:InterestExpense |
| Interest expense | 6 months2017-07-01 to 2017-12-31 | $137.0m | us-gaap:InterestExpense |
| Income tax | 3 months2017-10-01 to 2017-12-31 | −$7.9m | us-gaap:IncomeTaxExpenseBenefit |
| Income tax | 6 months2017-07-01 to 2017-12-31 | −$33.2m | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 3 months2017-10-01 to 2017-12-31 | $109.2m | us-gaap:NetIncomeLoss |
| Net income | 6 months2017-07-01 to 2017-12-31 | $89.5m | us-gaap:NetIncomeLoss |
| Diluted EPS | 3 months2017-10-01 to 2017-12-31 | $0.15 | us-gaap:EarningsPerShareDiluted |
| Diluted EPS | 6 months2017-07-01 to 2017-12-31 | $0.12 | us-gaap:EarningsPerShareDiluted |
| Basic EPS | 3 months2017-10-01 to 2017-12-31 | $0.15 | us-gaap:EarningsPerShareBasic |
| Basic EPS | 6 months2017-07-01 to 2017-12-31 | $0.12 | us-gaap:EarningsPerShareBasic |
| Diluted shares (weighted) | 3 months2017-10-01 to 2017-12-31 | 752,700,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Diluted shares (weighted) | 6 months2017-07-01 to 2017-12-31 | 752,500,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Operating cash flow | 6 months2017-07-01 to 2017-12-31 | $307.8m | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Capital expenditure | 6 months2017-07-01 to 2017-12-31 | $232.2m | us-gaap:PaymentsToAcquireProductiveAssets |
| Dividends paid | 6 months2017-07-01 to 2017-12-31 | $187.3m | us-gaap:PaymentsOfDividendsCommonStock |
| Share repurchases | 6 months2017-07-01 to 2017-12-31 | $0 | us-gaap:PaymentsForRepurchaseOfCommonStock |
| Cash and equivalents | At period end2017-12-31 | $400.1m | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Current assets | At period end2017-12-31 | $3.88bn | us-gaap:AssetsCurrent |
| Total assets | At period end2017-12-31 | $23.45bn | us-gaap:Assets |
| Current liabilities | At period end2017-12-31 | $4.16bn | us-gaap:LiabilitiesCurrent |
| Total liabilities | At period end2017-12-31 | $13.38bn | us-gaap:Liabilities |
| Long-term debt | At period end2017-12-31 | $7.15bn | us-gaap:LongTermDebtNoncurrent |
| Current portion of debt | At period end2017-12-31 | $295.9m | us-gaap:DebtCurrent |
| Short-term borrowings | At period end2017-12-31 | $13.5m | us-gaap:ShortTermBorrowings |
| Shareholders' equity | At period end2017-12-31 | $9.43bn | us-gaap:StockholdersEquity |
Source: SEC EDGAR, the filing index for accession 0001024305-18-000006. Last ingested by Listed: Nov 11, 2026, 03:30 ET. Listed shows no prices and gives no investment advice.